| 标题 |
Pomalidomide, dexamethasone, and daratumumab immediately after lenalidomide-based treatment in patients with multiple myeloma: updated efficacy, safety, and health-related quality of life results from the phase 2 MM-014 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Leukemia & Lymphoma 作者:Nizar J. Bahlis; David S. Siegel; Gary J. Schiller; Christy Samaras; Michaël Sébag; et al 出版日期:2022-02-08 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)